Pharmaceutical Companies Missing an Opportunity to Show Sustainable Supply Chain Leadership

Unique Tool Benchmarks Pharma Environmental Sustainability Goals

New York City (August 4, 2011) – Green Research, a New York-based corporate sustainability research and advisory firm, today released its benchmark of pharmaceutical company environmental sustainability goals. “The pharmas are all over the map,” said David Schatsky, principal analyst and founder of Green Research. “Some firms are leading in transparency with a large number of public, specific, quantitative goals; others have disclosed little of their plans.”

Corporations are beginning to compete on the strength of their commitments to environmental sustainability. Till now, though, they have lacked tools to help them benchmark their environmental aspirations against competitors.

Green Research inaugurated a new benchmarking tool by publishing a series of reports focusing on key industries with global scope. The first reports covered the computer industry, the food processing industry, telecommunications and banking. This new report analyzes the goals of pharmaceutical industry leaders Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Co, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi and Teva. The Green Research benchmark found that the pharmaceutical companies have announced an average of five or six specific, quantitative environmental sustainability goals each, with big variations among the firms. AstraZeneca had the highest number of goals, at 12.

Among the other findings are that 90 percent of the sustainability goals of the major pharmaceutical companies deal with their own internal operations. Very few companies have announced quantitative supply chain goals. This represents an opportunity for companies to claim leadership as the pharmaceutical supply chain accounts for a significant share of the potential environmental impact of this industry. “The pharmaceutical company that announces aggressive goals for the sustainability of its supply chain will stake out a position of leadership,” said Schatsky.

The pharmaceutical industry sustainability goals benchmarking research is available online at To learn more about the research, please visit or contact David Schatsky at 646-783-8337 or

David Schatsky


Leave a comment

Filed under press release

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s